The AVEO Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
What was AVEO Pharma’s price range in the past 12 months?
AVEO Pharma lowest stock price was $4.25 and its highest was $18.24 in the past 12 months.
What is AVEO Pharma’s market cap?
AVEO Pharma’s market cap is $180.39M.
What is AVEO Pharma’s price target?
The average price target for AVEO Pharma is $20.33. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $24.00 ,the lowest forecast is $18.00. The average price target represents 287.24% Increase from the current price of $5.25.
What do analysts say about AVEO Pharma?
AVEO Pharma’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
When is AVEO Pharma’s upcoming earnings report date?
AVEO Pharma’s upcoming earnings report date is Aug 05, 2021 which is tomorrow.
How were AVEO Pharma’s earnings last quarter?
AVEO Pharma released its earnings results on May 10, 2021. The company reported -$0.806 earnings per share for the quarter, missing the consensus estimate of -$0.548 by -$0.258.
Is AVEO Pharma overvalued?
According to Wall Street analysts AVEO Pharma’s price is currently Undervalued.
Does AVEO Pharma pay dividends?
AVEO Pharma does not currently pay dividends.
What is AVEO Pharma’s EPS estimate?
AVEO Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AVEO Pharma have?
AVEO Pharma has 34,360,000 shares outstanding.
What happened to AVEO Pharma’s price movement after its last earnings report?
AVEO Pharma reported an EPS of -$0.806 in its last earnings report, missing expectations of -$0.548. Following the earnings report the stock price went up 2.955%.
Which hedge fund is a major shareholder of AVEO Pharma?
Currently, no hedge funds are holding shares in AVEO